Premium
Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
Author(s) -
Brogi Simone,
Calderone Vincenzo
Publication year - 2020
Publication title -
british journal of clinical pharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14343
Subject(s) - favipiravir , tocilizumab , virology , repurposing , drug repositioning , medicine , ribavirin , proteases , viral pneumonia , protease , virus , pneumonia , pharmacology , biology , drug , covid-19 , immunology , hepatitis c virus , disease , enzyme , infectious disease (medical specialty) , rheumatoid arthritis , ecology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom